orywireNews that matters in AmericaReporting on public life, technology, money, and policy in the United States.
orywireTag
Published coverage grouped by topic.
NHS England says eligible men with early, low or intermediate-risk prostate cancer will be offered SABR radiotherapy, a more targeted treatment usually given in five doses. Patients should ask their specialist team whether it is suitable for their diagnosis and treatment plan.
More tagged coverage will appear here.